Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

When the Covid-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare.

15 Feb 2021

ESC Acute CardioVascular Care 2021 highlights urgent cardiac care during COVID-19 pandemic

International experience on treatment of COVID-19 and maintaining emergency cardiac services during the pandemic will be revealed at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology.

15 Feb 2021

Nanobodies protect against SARS-CoV-2 variants in animal model

Nanobodies are a potential therapeutic strategy for treating COVID-19. While many previous studies report nanobodies active against SARS-CoV-2 in vitro, none have been evaluated via animal models' intranasal administration.

15 Feb 2021

Only 25% of SARS-CoV-2 infections are detected in the UK: Study

A new preprint research paper posted to the medRxiv server estimates the number of infections that are diagnosed from testing alone as being about a fourth of the total.

15 Feb 2021

Premature relaxation of restrictions following SARS-CoV-2 vaccination could lead to new mutations

A new preprint research paper posted to the medRxiv* server addresses the need to assess this risk by examining whether SARS-CoV-2 transmission can interact with vaccination rates to select vaccine-resistant strains. The study aims to provide data to shape effective countermeasures against the threat of viral resistance.

14 Feb 2021

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.

14 Feb 2021

New mouse model of SARS-CoV-2 infection reflects features of human infection

Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.

14 Feb 2021

SARS-CoV-2's resistance to remdesivir in vitro

A new preprint research paper posted to the bioRxiv server discusses the emergence of mutations in the SARS-CoV-2 virus, allowing it to escape the effects of the most commonly used antiviral drug, remdesivir.

14 Feb 2021

SARS-CoV-2 was in NYC a good month before it was first identified, say researchers

Researchers at Icahn School of Medicine at Mount Sinai in New York have provided evidence suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was infecting people in New York City (NYC) at least one month before the first case was officially documented in the city.

14 Feb 2021

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Feb 2021

Akkure Genomics raises €1.2 million to accelerate roll-out of its next-generation clinical trials platform

Akkure Genomics, an Irish digital health scaleup which is developing a disruptive MedTech platform for the global clinical trials industry, has raised just over €1.2 million in a crowdfunding campaign from 318 investors.

13 Feb 2021

Study finds early risk factors for heightened anxiety in young adults during COVID-19

A new study has identified early risk factors that predicted heightened anxiety in young adults during the coronavirus (COVID-19) pandemic.

12 Feb 2021

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.

12 Feb 2021

Rethinking classical epidemiological modeling in light of COVID-19 pandemic

Researchers recently developed an epidemiological model to explore the impact of individual variation in susceptibility and infectivity on transmission dynamics of an infectious disease across inhomogeneous populations.

12 Feb 2021

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Researchers in the U.S. have demonstrated how dominant energetic landscape mappings or glue points, along with sequence alignment information can potentially identify key residue mutations and spike protein deletions tied with emerging variants.

12 Feb 2021

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

Researchers at the Southern Illinois University, U.S.A. have presented a comprehensive and well-validated set of working protocols for sequencing high-quality SARS-CoV-2 genomes in high throughput from patient samples.

12 Feb 2021

$1 million funding for Australian-first plan to boost primary care research

An Australian-first plan to boost primary care research and drive improved patient outcomes, has been backed by $1 million in grant funding.

12 Feb 2021

AI-assisted video analysis can help doctors to diagnose Parkinson’s disease at an early stage

Scientists from Skoltech and A.I. Burnazyan Federal Medical and Biophysical Center have designed and developed a second opinion system, based on AI-assisted video analysis, which can help medical professionals to objectively assess patients with Parkinson’s disease (PD) even at an early stage.

12 Feb 2021

Research could help improve hand hygiene in offices using new 'smart' hand sanitizers

'Smart' hand sanitizers that can provide data on workplace hand hygiene are being trialed across the country, as part of research by the Universities of Sheffield and Leeds into how best to engage people with the latest Covid-19 workplace hand hygiene guidance.

12 Feb 2021

At-home, mail-in testing kit can accurately test sperm up to 52 hours after sample collection

Some 15% of couples struggle with infertility. When couples fail to conceive, guidelines recommend both the man and woman undergo a tandem fertility evaluation.

12 Feb 2021

Pandemic News and Research

Further Reading

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

ESC Acute CardioVascular Care 2021 highlights urgent cardiac care during COVID-19 pandemic

Nanobodies protect against SARS-CoV-2 variants in animal model

Only 25% of SARS-CoV-2 infections are detected in the UK: Study

Premature relaxation of restrictions following SARS-CoV-2 vaccination could lead to new mutations

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

New mouse model of SARS-CoV-2 infection reflects features of human infection

SARS-CoV-2's resistance to remdesivir in vitro

SARS-CoV-2 was in NYC a good month before it was first identified, say researchers

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Akkure Genomics raises €1.2 million to accelerate roll-out of its next-generation clinical trials platform

Study finds early risk factors for heightened anxiety in young adults during COVID-19

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Rethinking classical epidemiological modeling in light of COVID-19 pandemic

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

$1 million funding for Australian-first plan to boost primary care research

AI-assisted video analysis can help doctors to diagnose Parkinson’s disease at an early stage

Research could help improve hand hygiene in offices using new 'smart' hand sanitizers

At-home, mail-in testing kit can accurately test sperm up to 52 hours after sample collection

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News